tiprankstipranks
MEDICLIN AG (GB:0NDG)
LSE:0NDG
UK Market
0NDG
MEDICLIN
RESEARCH TOOLSreports

MEDICLIN (0NDG) Ratios

0 Followers

MEDICLIN Ratios

GB:0NDG's free cash flow for Q4 2025 was €-1.92. For the 2025 fiscal year, GB:0NDG's free cash flow was decreased by € and operating cash flow was €-0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Mar 23
Liquidity Ratios
Current Ratio
 1.62 1.62 1.79 1.75 1.53
Quick Ratio
 1.58 1.58 1.75 1.71 1.48
Cash Ratio
 0.44 0.44 0.65 0.67 0.52
Solvency Ratio
 0.04 0.14 0.11 0.11 0.11
Operating Cash Flow Ratio
 0.61 0.61 0.49 0.46 0.20
Short-Term Operating Cash Flow Coverage
 3.50 3.50 43.23 2.89 1.29
Net Current Asset Value
€ -366.92M€ -366.92M€ -385.58M€ -384.65M€ -444.78M
Leverage Ratios
Debt-to-Assets Ratio
 0.44 0.44 0.51 0.54 0.55
Debt-to-Equity Ratio
 1.57 1.57 2.09 2.45 2.40
Debt-to-Capital Ratio
 0.61 0.61 0.68 0.71 0.71
Long-Term Debt-to-Capital Ratio
 0.05 0.05 0.23 0.25 0.24
Financial Leverage Ratio
 3.53 3.53 4.07 4.49 4.38
Debt Service Coverage Ratio
 0.59 1.81 3.84 1.95 2.45
Interest Coverage Ratio
 1.85 1.85 2.23 0.53 1.84
Debt to Market Cap
 0.26 0.24 0.58 0.73 0.55
Interest Debt Per Share
 8.67 8.67 10.28 10.61 10.81
Net Debt to EBITDA
 8.29 3.23 3.35 3.60 4.52
Profitability Margins
Gross Profit Margin
14.51%14.51%83.20%81.44%81.16%
EBIT Margin
4.90%4.90%7.49%2.09%2.89%
EBITDA Margin
4.90%12.58%14.21%13.87%13.03%
Operating Profit Margin
4.90%4.90%7.14%1.74%2.77%
Pretax Profit Margin
4.49%4.49%4.29%-1.19%1.39%
Net Profit Margin
3.25%3.25%3.32%-1.48%1.34%
Continuous Operations Profit Margin
3.30%3.30%3.33%-1.47%1.38%
Net Income Per EBT
72.41%72.41%77.33%124.02%96.56%
EBT Per EBIT
91.57%91.57%60.05%-68.30%50.09%
Return on Assets (ROA)
2.90%2.90%2.74%-1.22%1.03%
Return on Equity (ROE)
10.71%10.24%11.16%-5.50%4.51%
Return on Capital Employed (ROCE)
5.36%5.36%7.23%1.79%2.62%
Return on Invested Capital (ROIC)
3.80%3.80%5.40%1.55%2.44%
Return on Tangible Assets
2.95%2.95%2.82%-1.26%1.10%
Earnings Yield
15.60%14.50%21.61%-8.40%5.52%
Efficiency Ratios
Receivables Turnover
 4.31 4.31 4.17 4.76 5.04
Payables Turnover
 46.13 46.13 9.77 10.73 9.16
Inventory Turnover
 122.98 122.98 16.41 18.57 14.97
Fixed Asset Turnover
 1.56 1.56 1.40 1.42 1.30
Asset Turnover
 0.89 0.89 0.83 0.83 0.77
Working Capital Turnover Ratio
 6.19 6.77 5.76 6.64 9.81
Cash Conversion Cycle
 79.71 79.71 72.41 62.33 56.92
Days of Sales Outstanding
 84.66 84.66 87.52 76.68 72.39
Days of Inventory Outstanding
 2.97 2.97 22.24 19.65 24.38
Days of Payables Outstanding
 7.91 7.91 37.36 34.01 39.84
Operating Cycle
 87.62 87.62 109.76 96.34 96.76
Cash Flow Ratios
Operating Cash Flow Per Share
 2.10 2.10 1.70 1.64 0.73
Free Cash Flow Per Share
 1.08 1.08 0.76 0.85 0.18
CapEx Per Share
 1.02 1.02 0.94 0.79 0.55
Free Cash Flow to Operating Cash Flow
 0.52 0.52 0.45 0.52 0.25
Dividend Paid and CapEx Coverage Ratio
 1.98 1.98 1.80 2.08 1.33
Capital Expenditure Coverage Ratio
 2.06 2.06 1.80 2.08 1.33
Operating Cash Flow Coverage Ratio
 0.26 0.26 0.17 0.16 0.07
Operating Cash Flow to Sales Ratio
 0.13 0.13 0.11 0.11 0.05
Free Cash Flow Yield
31.48%29.27%31.21%31.52%5.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.41 6.90 4.63 -11.90 18.11
Price-to-Sales (P/S) Ratio
 0.21 0.22 0.15 0.18 0.24
Price-to-Book (P/B) Ratio
 0.66 0.71 0.52 0.65 0.82
Price-to-Free Cash Flow (P/FCF) Ratio
 3.18 3.42 3.20 3.17 19.84
Price-to-Operating Cash Flow Ratio
 1.64 1.76 1.43 1.64 4.94
Price-to-Earnings Growth (PEG) Ratio
 -0.22 1.79 -0.01 0.06 0.03
Price-to-Fair Value
 0.66 0.71 0.52 0.65 0.82
Enterprise Value Multiple
 12.54 5.01 4.43 4.87 6.38
Enterprise Value
 482.05M 494.40M 471.51M 492.79M 585.63M
EV to EBITDA
 12.54 5.01 4.43 4.87 6.38
EV to Sales
 0.61 0.63 0.63 0.67 0.83
EV to Free Cash Flow
 9.37 9.61 13.14 12.19 67.93
EV to Operating Cash Flow
 4.83 4.95 5.85 6.32 16.91
Tangible Book Value Per Share
 4.90 4.90 4.17 3.65 3.24
Shareholders’ Equity Per Share
 5.24 5.24 4.68 4.12 4.40
Tax and Other Ratios
Effective Tax Rate
 0.26 0.26 0.22 -0.23 <0.01
Revenue Per Share
 16.52 16.52 15.76 15.37 14.84
Net Income Per Share
 0.54 0.54 0.52 -0.23 0.20
Tax Burden
 0.72 0.72 0.77 1.24 0.97
Interest Burden
 0.92 0.92 0.57 -0.57 0.48
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.10 0.10 0.03 0.02 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 3.92 3.92 3.23 -7.24 3.56
Currency in EUR